文献速递脊柱关节炎其他结缔组织病

脊柱关节炎、急性前葡萄膜炎与克罗恩病中共有和特异的肠道微生物群

Shared and Distinct Gut Microbiota in Spondyloarthritis, Acute Anterior Uveitis, and Crohn's Disease.
PubMed 文献 · Arthritis Rheumatol · 2023-10-19

该研究对德国脊柱关节炎起始队列中277例患者(72例克罗恩病、103例急性前葡萄膜炎、102例脊柱关节炎)及62例无炎症性疾病的背痛对照进行粪便16S核糖体RNA测序,采用判别性统计方法分离微生物疾病信号与潜在混杂因素。研究识别出以毛螺菌科(Lachnospiraceae) taxon低丰度为特征的共有免疫介导疾病信号,脊柱关节炎患者柯林斯菌属(Collinsella)富集,HLA-B27阳性个体普拉梭菌属(Faecalibacterium)富集,克罗恩病患者瘤胃球菌属(Ruminococcus) taxon丰度更高。作者结论支持脊柱关节炎及相关炎症病理中存在共同肠道菌群失调,并提示潜在疾病活动介质。

要点

  • 脊柱关节炎、急性前葡萄膜炎和克罗恩病共享毛螺菌科低丰度信号,以Fusicatenibacter最显著。
  • 脊柱关节炎患者柯林斯菌属富集,HLA-B27阳性个体普拉梭菌属富集。
  • 克罗恩病患者瘤胃球菌属taxon丰度更高,既往传统/合成DMARD治疗与阿克曼菌属增加相关。

核心结论

  • 作者认为研究支持脊柱关节炎及相关炎症病理中存在共同肠道菌群失调,并揭示共有和疾病特异性微生物关联及疾病活动潜在介质。
  • 作者指出需要验证性研究明确Fusicatenibacter在肠-关节炎症中的作用,并需宏基因组分辨率理解普拉梭菌属共生菌与HLA-B27的关系。

研究设计与样本

  • 研究对德国脊柱关节炎起始队列中277例患者(72例克罗恩病、103例急性前葡萄膜炎、102例脊柱关节炎)及62例无炎症性疾病的背痛对照的粪便样本进行16S核糖体RNA测序。
  • 采用判别性统计方法分离微生物疾病信号与潜在混杂因素。
  • 患者入组前未接受或超过3个月未接受生物改善病情抗风湿药(DMARD)治疗,以更好近似真实基线疾病信号。

主要发现

  • 研究识别出以毛螺菌科(Lachnospiraceae)taxon低丰度(相对于对照)为特征的共有免疫介导疾病信号,最显著为Fusicatenibacter,其在接受非甾体抗炎药单药治疗的对照中丰度最高,并暗示部分介导较高的血清C反应蛋白。
  • 脊柱关节炎患者显示柯林斯菌属(Collinsella)富集,而HLA-B27阳性个体显示普拉梭菌属(Faecalibacterium)富集。
  • 克罗恩病患者瘤胃球菌属(Ruminococcus)taxon丰度更高,既往传统/合成DMARD治疗与阿克曼菌属(Akkermansia)增加相关。

局限性

  • 作者指出需要验证性研究明确Fusicatenibacter在肠-关节炎症中的作用。
  • 作者指出需要宏基因组分辨率理解普拉梭菌属共生菌与HLA-B27的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Spondyloarthritis (SpA) is a group of immune-mediated diseases highly concomitant with nonmusculoskeletal inflammatory disorders, such as acute anterior uveitis (AAU) and Crohn's disease (CD). The gut microbiome represents a promising avenue to elucidate shared and distinct underlying pathophysiology. METHODS: We performed 16S ribosomal RNA sequencing on stool samples of 277 patients (72 CD, 103 AAU, and 102 SpA) included in the German Spondyloarthritis Inception Cohort and 62 back pain controls without any inflammatory disorder. Discriminatory statistical methods were used to disentangle microbial disease signals from one another and a wide range of potential confounders. Patients were naive to or had not received treatment with biological disease-modifying antirheumatic drugs (DMARDs) for >3 months before enrollment, providing a better approximation of a true baseline disease signal. RESULTS: We identified a shared, immune-mediated disease signal represented by low abundances of Lachnospiraceae taxa relative to controls, most notably Fusicatenibacter, which was most abundant in controls receiving nonsteroidal antiinflammatory drug monotherapy and implied to partially mediate higher serum C-reactive protein. Patients with SpA showed an enrichment of Collinsella, whereas human leukocyte antigen (HLA)-B27+ individuals displayed enriched Faecalibacterium. CD patients had higher abundances of a Ruminococcus taxon, and previous conventional/synthetic DMARD therapy was associated with increased Akkermansia. CONCLUSION: Our work supports the existence of a common gut dysbiosis in SpA and related inflammatory pathologies. We reveal shared and disease-specific microbial associations and suggest potential mediators of disease activity. Validation studies are needed to clarify the role of Fusicatenibacter in gut-joint inflammation, and metagenomic resolution is needed to understand the relationship between Faecalibacterium commensals and HLA-B27.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Essex M, Rios Rodriguez V, Rademacher J, et al. Shared and Distinct Gut Microbiota in Spondyloarthritis, Acute Anterior Uveitis, and Crohn's Disease. Arthritis Rheumatol. 2023. PMID: 37471465. doi:10.1002/art.42658

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。